Navigation Links
PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
Date:5/17/2012

LAKE FOREST, Ill., May 17, 2012 /PRNewswire/ -- Amy Langan, Vice President of Marketing and Business Development, announced that PharMEDium will highlight its enhanced labeling for sterile intravenous compounded ICU Services at the National Teaching Institute (NTI) and Critical Care Exposition, May 19-24, 2012 in Orlando, Florida.

(Logo: http://photos.prnewswire.com/prnh/20120517/CG09355LOGO)

Ms. Langan invites critical care professionals to visit Booth #2668 to see how the enhanced labels help clinicians and pharmacy staff with easier drug and dose recognition when stocking, retrieving, and administering compounded services from PharMEDium.  Onsite PharMEDium associates will showcase the functionality and appearance of the enhanced labels and packaging, which are resultant of PharMEDium's ongoing commitment to patient safety, quality and innovation.

"Attendees at the NTI and Critical Care Exposition anticipate seeing new ideas, approaches and innovations designed to help them provide patient safety and quality of care for critically ill patients," stated David N. Jonas, CEO and Chairman of the Board.   "As the key educational and informational event for critical care caregivers, this meeting is an ideal forum for PharMEDium to present our new and enhanced labeling for ICU services."

At the 2011 Chicago exposition, PharMEDium conducted market research with over 1000 critical care nurses, enabling PharMEDium to gain a broader understanding of the medication administration challenges critical care nurses face.  The findings were the foundation for several of the enhancements now in the market. For example, service being delivered with new labels includes Phenylephrine, Norepinephrine and Vasopressin ready-to-use compounded sterile preparations.  David N. Jonas, PharMEDium Chairman and CEO, added, "We have received positive feedback about the labeling enhancements.  We're enthusiastic to be a part of this professional group and PharMEDium is proud to be a corporate sponsor of the American Association of Critical Care Nurses."

About PharMEDium
PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium® network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and federal regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit http://www.pharmedium.com.

 


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Adds O.R. Medication Verification System
2. PharMEDiums Technology Helps Hospital Pharmacists Ensure Safety
3. PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
4. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
5. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
6. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
7. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
8. PharMEDium Elects William R. Spalding to Board of Directors
9. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. Delcath Highlights First Quarter 2012 And Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):